Product Details
Hexaxim Vaccine**
Diphtheria, tetanus, pertussis (acellular, component), hepatitis B (rDNA), poliomyelitis (inactivated) & haemophilus influenzae type B conjugate vaccine (adsorbed)0.5 mL
Suspension for injection
ROA
Intramuscular
Applicant Name
Sanofi-Aventis Nigeria Limited
NRN
A6-0447
Status
Active
Composition
Each dose (0.5 mL) contains: Diphtheria Toxoid not less than 20 IU (30 Lf), Tetanus Toxoid not less than 40 IU (10 Lf), Bordetella pertussis antigens (Pertussis Toxoid 25 micrograms, Filamentous Haemagglutinin 25 micrograms), Poliovirus (Inactivated) (Type 1 (Mahoney) 40 D-antigen units, Type 2 (MEF-1) 8 D-antigen units, Type 3 (Saukett) 32 D-antigen units), Hepatitis B surface antigen 10 micrograms, Haemophilus influenzae type b polysaccharide 12 micrograms (Polyribosylribitol Phosphate) conjugated to Tetanus protein 22-36 micrograms. The vaccine may contain traces of glutaraldehyde, formaldehyde, neomycin, streptomycin and polymyxin B which are used during the manufacturing process. Excipient with known effect: Phenylalanine 85 micrograms
ATC Code
Product Category
Vaccines and Biologics
Marketing Category
Prescription-only Medicine (POM)
Packsize
0.5 mL x 1's (in Prefilled syringe)
Product Description
Suspension for injection in pre-filled syringe. Hexaxim is a whitish, cloudy suspension
Manufacturer Name
Sanofi Pasteur S.A.
Manufacturer Country
FRANCE
Approval Date
2023-02-23
Expiry Date
2028-02-22